Skip to main content

Table 1 Baseline characteristics of the 14 participants with exercise induced bronchoconstriction

From: An open-label study examining the effect of pharmacological treatment on mannitol- and exercise-induced airway hyperresponsiveness in asthmatic children and adolescents with exercise-induced bronchoconstriction

Subject BMI (kg/m2) Age FEV1 (L) FEV1% predicted FVC (liter) FEV1% predicted Max fall FEV1 in ECT (%) RDR mannitol (%/mg) PD15 mannitol
MCT positive          
A 39.7   3.24 83.5 3.98 84.5 15.7 0.059 293
B 25.0   2.34 128.6 2.86 134.9 29.1 0.034 569
C 16.4   2.02 125.3 2.56 133.3 61.7 0.120 133
D 17.2   3.09 109.2 3.97 116.8 48.7 0.155 102
E 36.4   2.43 92.4 2.82 89.5 16.0 0.037 512
F 29.7   3.54 101.4 4.89 115.9 29.7 0.313 49
G 25.8   4.45 100 5.82 107.6 22.5 0.039 475
Mean ± SD or median (IQR) 25.8 (19.1) 14.1 ± 3.5 3.01 ± 0.83 105.8 ± 16.5 3.84 ± 1.20 111.8 ± 19.6 29.1 (32.7) 0.059 (0.118) 293 (410)
MCT negative          
H 15.5   1.92 85.3 2.44 90.4 46.8 0.034  
I 35.0   4.52 113.6 5.02 103.9 20.8 0.030  
J 37.1   2.87 101.4 3.62 105.5 16.9 0.020  
K 30.0   3.41 104.9 4.85 130 42.9 0.075  
L 30.7   3.69 100.5 4.64 104.5 17.6 0.020  
M 35.2   5.78 136.3 7.23 140.4 18.3 0.030  
N 14.8   2.56 133.3 3.08 134.5 17.9 0  
Mean ± SD or (Median) 30.7 (19.7) 14.1 ± 3 3.53 ± 1.29 110.8 ± 18.5 4.41 ± 1.57 115.6 ± 19 18.3 (25.3) 0.030 (0.014)  
p-value 0.45 ns 0.22 0.24 0.31 0.45 0.29 0.03  
  1. ns = non significant.